Price
$5.06
Decreased by -5.24%
Dollar volume (20D)
3.33 M
ADR%
5.28
Earnings report date
Jun 5, 2025
Shares float
113.16 M
Shares short
4.61 M [4.07%]
Shares outstanding
131.51 M
Market cap
702.24 M
Beta
1.31
Price/earnings
N/A
20D range
4.71 5.79
50D range
4.71 6.97
200D range
4.71 9.87

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.

It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems.

The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils.

In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools.

The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations.

It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries.

The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015.

Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Aug 5, 24 -0.08
Decreased by -166.67%
-0.03
Decreased by -166.67%
May 8, 24 -0.05
Increased by 0.00%
-0.04
Decreased by -25.00%
Feb 28, 24 0.04
Decreased by -33.33%
0.01
Increased by +300.00%
Nov 7, 23 -0.05
Decreased by -225.00%
0.03
Decreased by -266.67%
Aug 8, 23 -0.03
Decreased by -200.00%
0.03
Decreased by -200.00%
May 9, 23 -0.05
Decreased by -600.00%
0.03
Decreased by -266.67%
Feb 28, 23 0.06
Increased by +100.00%
0.05
Increased by +20.00%
Nov 9, 22 0.04
Increased by +100.00%
0.02
Increased by +100.00%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Jun 30, 24 46.62 M
Decreased by -6.19%
-10.43 M
Decreased by -137.78%
Decreased by -22.38%
Decreased by -153.47%
Mar 31, 24 44.86 M
Increased by +20.96%
-6.17 M
Increased by +9.37%
Decreased by -13.75%
Increased by +25.07%
Dec 31, 23 58.23 M
Increased by +20.48%
5.50 M
Increased by +55.94%
Increased by +9.45%
Increased by +29.43%
Sep 30, 23 48.00 M
Increased by +18.59%
-6.46 M
Decreased by -487.52%
Decreased by -13.45%
Decreased by -426.78%
Jun 30, 23 49.69 M
Increased by +23.74%
-4.39 M
Decreased by -633.78%
Decreased by -8.83%
Decreased by -493.00%
Mar 31, 23 37.09 M
Increased by +5.77%
-6.81 M
Decreased by -215.43%
Decreased by -18.35%
Decreased by -198.22%
Dec 31, 22 48.34 M
Increased by +24.28%
3.53 M
Increased by +1.47 K%
Increased by +7.30%
Increased by +1.16 K%
Sep 30, 22 40.48 M
Increased by +17.75%
1.67 M
Increased by +4.45%
Increased by +4.12%
Decreased by -11.29%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY